Join Fund Library now and get free access to personalized features to help you manage your investments.
Sector Equity
Click for more information on Fundata’s ESG Grade
Click for more information on Fundata’s ESG Grade.
|
NAVPS (05-15-2024) |
$38.68 |
|---|---|
| Change |
$0.41
(1.08%)
|
As at April 30, 2024
As at March 31, 2024
As at February 29, 2024
Loading...
Inception Return (September 25, 2001): 6.02%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -1.75% | 4.79% | 14.33% | 7.51% | 8.30% | 6.76% | 5.03% | 6.51% | 8.71% | 9.73% | 8.31% | 8.93% | 7.45% | 9.90% |
| Benchmark | -1.82% | 4.10% | 16.91% | 4.68% | 8.73% | 5.66% | 7.59% | 13.51% | 8.86% | 8.98% | 8.12% | 8.95% | 7.25% | 7.22% |
| Category Average | -3.74% | 20.47% | 20.47% | 6.33% | 21.51% | 11.00% | 2.93% | 10.99% | 9.65% | 10.68% | 10.35% | 12.02% | 10.29% | 11.57% |
| Category Rank | 27 / 190 | 75 / 189 | 109 / 189 | 62 / 189 | 100 / 171 | 102 / 155 | 56 / 137 | 90 / 130 | 63 / 123 | 47 / 111 | 47 / 89 | 51 / 86 | 53 / 79 | 40 / 68 |
| Quartile Ranking | 1 | 2 | 3 | 2 | 3 | 3 | 2 | 3 | 3 | 2 | 3 | 3 | 3 | 3 |
| Return % | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -3.39% | 0.51% | 0.95% | 1.79% | -3.82% | -1.30% | 4.31% | 1.95% | 2.60% | 3.78% | 2.77% | -1.75% |
| Benchmark | -4.95% | 3.36% | 2.58% | -1.37% | -3.33% | -3.21% | 7.48% | 3.91% | 0.55% | 1.82% | 4.14% | -1.82% |
11.30% (January 2015)
-9.29% (June 2002)
| Return % | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 30.52% | 26.57% | -15.20% | 10.93% | 13.85% | 18.30% | 9.18% | 19.22% | -7.74% | 2.95% |
| Benchmark | 10.55% | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% |
| Category Average | 17.30% | 16.21% | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% |
| Quartile Ranking | 1 | 2 | 4 | 3 | 1 | 3 | 4 | 2 | 2 | 3 |
| Category Rank | 14/ 68 | 21/ 79 | 78/ 86 | 59/ 86 | 8/ 106 | 79/ 117 | 101/ 127 | 49/ 132 | 44/ 149 | 109/ 161 |
30.52% (2014)
-15.20% (2016)
| Name | Percent |
|---|---|
| US Equity | 60.32 |
| International Equity | 35.60 |
| Cash and Equivalents | 4.05 |
| Foreign Corporate Bonds | 0.04 |
| Other | -0.01 |
| Name | Percent |
|---|---|
| Healthcare | 90.23 |
| Cash and Cash Equivalent | 4.05 |
| Consumer Services | 2.11 |
| Industrial Goods | 1.87 |
| Consumer Goods | 1.71 |
| Other | 0.03 |
| Name | Percent |
|---|---|
| North America | 64.16 |
| Europe | 35.85 |
| Other | -0.01 |
| Name | Percent |
|---|---|
| UnitedHealth Group Inc | - |
| Novo Nordisk A/S Cl B | - |
| Eli Lilly and Co | - |
| Thermo Fisher Scientific Inc | - |
| Roche Holding AG - Partcptn | - |
| Stryker Corp | - |
| Icon PLC | - |
| Fidelity U.S. Money Market Investment Trust O | - |
| Boston Scientific Corp | - |
| HCA Healthcare Inc | - |
Fidelity Global Health Care Class Series B
Median
Other - Sector Equity
| Standard Deviation | 12.25% | 11.82% | 12.73% |
|---|---|---|---|
| Beta | 0.56% | 0.45% | 0.39% |
| Alpha | 0.01% | 0.05% | 0.07% |
| Rsquared | 0.37% | 0.35% | 0.15% |
| Sharpe | 0.24% | 0.60% | 0.70% |
| Sortino | 0.31% | 0.81% | 0.92% |
| Treynor | 0.05% | 0.16% | 0.23% |
| Tax Efficiency | 100.00% | 100.00% | 100.00% |
| Volatility |
|
|
|
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 9.37% | 12.25% | 11.82% | 12.73% |
| Beta | 0.60% | 0.56% | 0.45% | 0.39% |
| Alpha | 0.03% | 0.01% | 0.05% | 0.07% |
| Rsquared | 0.68% | 0.37% | 0.35% | 0.15% |
| Sharpe | 0.39% | 0.24% | 0.60% | 0.70% |
| Sortino | 0.90% | 0.31% | 0.81% | 0.92% |
| Treynor | 0.06% | 0.05% | 0.16% | 0.23% |
| Tax Efficiency | 100.00% | 100.00% | 100.00% | 100.00% |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
| Start Date | September 25, 2001 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Commission Based Advice |
| Legal Status | Corporation |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $22 |
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| FID244 |
The Fund aims to achieve long-term capital growth. It seeks a similar return to its underlying fund, which is also managed by Fidelity, by investing substantially all of its assets in units of that fund. The underlying fund aims to achieve long-term capital growth by investing primarily in equity securities of companies anywhere in the world that design, make or sell products or services related to health care and medicine.
The strategies described below relate to the Fund and the underlying fund, Fidelity Global Health Care Fund. To meet the Fund’s objectives, the portfolio management team of the underlying fund: Invests in companies in the health care industry, including biotechnology firms, and health management organizations and companies involved in hospital management, medical products, and pharmaceuticals.
| Name | Start Date |
|---|---|
| Alex Gold | 07-19-2019 |
| Amit Lodha | 07-19-2019 |
| Judith Finegold | 02-21-2020 |
| Fund Manager | Fidelity Investments Canada ULC |
|---|---|
| Advisor | Fidelity Investments Canada ULC |
| Custodian | State Street Trust Company Canada |
| Registrar | Fidelity Investments Canada ULC |
| Distributor | - |
| Auditor | PriceWaterhouseCoopers LLP |
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 25 |
| PAC Subsequent | 25 |
| SWP Allowed | Yes |
| SWP Min Balance | 5,000 |
| SWP Min Withdrawal | 50 |
| MER | 2.25% |
|---|---|
| Management Fee | 1.85% |
| Load | Back Fee Only |
| FE Max | 5.00% |
| DSC Max | - |
| Trailer Fee Max (FE) | 1.00% |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | - |
| Trailer Fee Max (LL) | - |
Join Fund Library now and get free access to personalized features to help you manage your investments.
Fund Library
